Progression Risk Stratification of Asymptomatic Waldenström Macroglobulinemia

BACKGROUND: Waldenström macroglobulinemia (WM) is preceded by asymptomatic WM (AWM), for which the risk of progression to overt disease is not well defined. METHODS: We studied 439 patients with AWM, who were diagnosed and observed at Dana-Farber Cancer Institute between 1992 and 2014. RESULTS: Duri...

Szczegółowa specyfikacja

Zapisane w:
Opis bibliograficzny
Wydane w:J Clin Oncol
Główni autorzy: Bustoros, Mark, Sklavenitis-Pistofidis, Romanos, Kapoor, Prashant, Liu, Chia-Jen, Kastritis, Efstathios, Zanwar, Saurabh, Fell, Geoffrey, Abeykoon, Jithma P., Hornburg, Kalvis, Neuse, Carl Jannes, Marinac, Catherine R., Liu, David, Soiffer, Jenny, Gavriatopoulou, Maria, Boehner, Cody, Cappuccio, Joseph M., Dumke, Henry, Reyes, Kaitlen, Soiffer, Robert J., Kyle, Robert A., Treon, Steven P., Castillo, Jorge J., Dimopoulos, Meletios A., Ansell, Stephen M., Trippa, Lorenzo, Ghobrial, Irene M.
Format: Artigo
Język:Inglês
Wydane: American Society of Clinical Oncology 2019
Hasła przedmiotowe:
ORIGINAL REPORTS
Dostęp online:https://ncbi.nlm.nih.gov/pmc/articles/PMC6544461/
https://ncbi.nlm.nih.gov/pubmed/30990729
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1200/JCO.19.00394
Etykiety: Dodaj etykietę
Nie ma etykietki, Dołącz pierwszą etykiete!

Podobne zapisy